A compound able to reverse the allegiance of innate immune system cells - turning them from tumor enablers into tumor opponents - caused breast tumors in mice to shrink and withdraw from distant metastases, scientists report.
A compound able to reverse the allegiance of innate immune system cells - turning them from tumor enablers into tumor opponents - caused breast tumors in mice to shrink and withdraw from distant metastases, scientists report.